Web Analytics Made Easy - StatCounter
Megapixl
Search results

Illustration: Glucagon-Like Peptide 2 (Glp-2) Peptide Molecule.

ID 35580175 © Molekuul | Megapixl.com

Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome, an orphan disease. Cartoon & wire representation. Secondary structure coloring.

CATEGORIES

EXCLUSIVE

Not to be used in commercial
designs and/or advertisements.
Click here for terms and conditions.
Glucagon-like peptide 2 (GLP-2) peptide molecule.

Royalty-Free

extended licenses

I-EL W-EL P-EL U-EL
Your image is downloading.

Sharing is not just caring, it's also about giving credit - add this image to your page and give credit to the talented photographer who captured it.:

© Molekuul | Megapixl.com
HTML code

KEYWORDS

acid amino atoms bowel drug glp glp2 glucagon helix like magnetic molecule nmr nuclear orphan pdb2l64 peptide polymer polypeptide protein recombinant resonance short structure syndrome teduglutide tedugluttide therapy treatment

More images on Dreamstime

Glucagon hypoglycemia drug molecule. Skeletal formula.
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome, an
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome, an
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity
Octreotide molecule. It is octapeptide, synthetic somatostatin analogue, inhibitor of growth hormone, glucagon, insulin. Molecule
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity

Similar Images

Types of Diabetes
GLP-1. Glucagon-like peptide-1
Types of Diabetes
3D rendering of Glucagon-like peptide 1 (GLP1, 7-36) molecule, a potent antihyperglycemic hormone.
GLP-1. Functions of Glucagon-like peptide-1
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome, an
Glucagon-like peptide-1. GLP-1 from blood vessel to pancreas, brain and stomach
GLP-1 mechanism of action. Glucagon-like peptide in pancreatic cell
Toll-like receptor 4 (TLR4, extracellular domain) bound to lipopolysaccharide (LPS) and MD-2. Involved in activating the innate
Glucagon-like peptide 1 (GLP1, 7-36) molecule, 3D rendering. Atoms are represented as spheres with conventional color coding:

More images by the same author

Tumor necrosis factor (TNF, cachexin, cachectin)
Gliadin derived peptide. Immunogenic breakdown product of gluten
Nitric oxide (NO) free radical and signaling molecule.
Human Erythropoietin (EPO)
Alcohol dehydrogenase (ADH) enzyme
Cellulose
Prostate-specific antigen
Lidocaine
Linoleic acid (LA)
Apolipoprotein A-I molecule
Thyroxine hormone molecule, chemical structure.
Alcohol ethanol, ethyl alcohol molecule, chemical structure. Skeletal formula.
View more